PR

Prestige BioPharma Limited

Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.

950210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Singapore
Address:
21 BIOPOLIS ROAD #04-24 NUCLEOS, SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Prestige BioPharma Limited is a biopharmaceutical company specializing in the development of biosimilars and innovative, first-in-class antibody drugs. The company pursues a dual-track strategy focused on both creating affordable, high-quality biosimilars to enhance patient access and discovering novel therapeutics and vaccines for life-threatening diseases. Its operations cover the full development lifecycle, from discovery and research to clinical development, registration, and commercialization. Prestige BioPharma aims to become a global innovation hub by fostering collaboration and advancing biopharmaceutical technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Prestige BioPharma Limited and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Audit Report / Information
감사보고서제출
Korean 21.8 KB
2025-09-19 00:00
Annual Report
사업보고서 (2025.06)
Korean 3.7 MB
2025-09-16 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.3 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 136.7 KB
2025-09-09 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.5 KB
2025-08-18 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 8.6 KB

Automate Your Workflow. Get a real-time feed of all Prestige BioPharma Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prestige BioPharma Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden IBT
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea 048530
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea 389470
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden IRLAB
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea 086890
IVF HARTMANN Holding AG Logo
Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.
Switzerland VBSN
Japan Tissue Engineering Co., Ltd. Logo
Pioneers regenerative medicine with tissue products, CDMO services, and research models.
Japan 7774

Talk to a Data Expert

Have a question? We'll get back to you promptly.